Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Stock
Stocks
002399
CNE100000P02
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shenzhen S.E.
31/08/2026
|
5-day change | 1st Jan Change | ||
| 10.04 CNY | -3.92% |
|
-4.11% | -14.84% |
| Market Cap | 13.34B 1.98B 1.71B 1.6B 1.46B 2.75B 189B 2.77B 19B 7.39B 95.84B 7.45B 7.29B 317B | P/E 2026 * |
17.3x | P/E 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 11.91B 1.77B 1.53B 1.43B 1.31B 2.46B 169B 2.47B 16.97B 6.6B 85.58B 6.66B 6.51B 283B | EV / Sales 2026 * |
2.06x | EV / Sales 2027 * | 2.23x |
| Free-Float |
14.33% | Yield 2026 * |
0.7% | Yield 2027 * | 0.8% |
| 1 day | -3.92% | ||
| 1 week | -4.11% | ||
| Current month | +3.61% | ||
| 1 month | +4.80% | ||
| 3 months | +1.01% | ||
| 6 months | -14.70% | ||
| Current year | -14.84% |
| 1 week | 9.91 |  | 10.78 |
| 1 month | 9.57 | | 11.57 |
| Current year | 8.5 | | 12.64 |
| 1 year | 8.5 | | 13.33 |
| 3 years | 6.89 | | 14.34 |
| 5 years | 6.89 | | 18.89 |
| 10 years | 6.89 | | 30.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yu Shan
CEO | Chief Executive Officer | 65 | 21/04/1998 |
Tan Li
PRN | Corporate Officer/Principal | 61 | 21/04/1998 |
Juan Chen
DFI | Director of Finance/CFO | 51 | 21/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Tan Li
BRD | Director/Board Member | 61 | 21/04/1998 |
Li Li
CHM | Chairman | 62 | 21/04/1998 |
Yu Shan
BRD | Director/Board Member | 65 | 21/04/1998 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/05/23 | Sell | 11,200 | 0.0009% | |||
| 26/05/21 | Other | Chief Financial Officer | 459,588 | 0.2088% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.92% | -4.11% | -22.17% | -12.62% | 2.06B | |
| -1.52% | -7.86% | +57.90% | +111.09% | 1,047B | |
| -0.82% | -1.62% | +50.05% | +62.37% | 646B | |
| +0.37% | -3.22% | +21.87% | +72.88% | 451B | |
| -1.64% | -4.75% | +35.59% | +35.54% | 355B | |
| -0.39% | -2.76% | +21.39% | +38.01% | 291B | |
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | |
| -0.59% | -3.15% | +49.83% | +67.70% | 234B | |
| -1.05% | -2.29% | -19.91% | -54.10% | 203B | |
| +0.45% | -0.27% | +29.84% | +91.34% | 181B | |
| Average | -0.74% | -2.67% | +22.59% | +42.37% | 366.13B | |
| Weighted average by Cap. | -0.18% | -3.46% | +36.88% | +64.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.78B 860M 740M 695M 634M 1.19B 81.79B 1.2B 8.23B 3.2B 41.5B 3.23B 3.16B 137B | 6.27B 934M 804M 755M 689M 1.29B 88.86B 1.3B 8.94B 3.48B 45.09B 3.51B 3.43B 149B |
| Net income | 858M 128M 110M 103M 94.21M 177M 12.15B 178M 1.22B 476M 6.16B 479M 469M 20.39B | 999M 149M 128M 120M 110M 206M 14.14B 207M 1.42B 554M 7.18B 558M 546M 23.74B |
| Net Debt | -1.43B -212M -183M -172M -157M -294M -20.21B -296M -2.03B -791M -10.25B -797M -780M -33.92B | 668M 99.38M 85.54M 80.33M 73.33M 138M 9.46B 139M 951M 370M 4.8B 373M 365M 15.87B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/08/26 | CN¥10.04 | -3.92% | 7,688,460 |
| 28/08/26 | CN¥10.45 | -1.42% | 5,347,000 |
| 27/08/26 | CN¥10.60 | +1.92% | 6,685,978 |
| 26/08/26 | CN¥10.40 | +0.87% | 8,545,934 |
| 25/08/26 | CN¥10.31 | +3.10% | 9,611,128 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 002399 Stock
Select your edition
All financial news and data tailored to specific country editions
